Social Media and Cancer Screening Information

NCT06712901 | Completed Results

• 2 other identifiers: HCI1834915R37CA259156-04
• Study Type: interventional
• Target: 2,030
• Locations: 1 country
• Sites: 1

Brief Summary

NORC/AmeriSpeak will recruit participants who meet the study criteria and invite them to complete a 15-minute survey. Participants will be randomly assigned to one of five conditions, with approximately 400 people in each condition, and will respond to various questions after viewing the study messaging. Once 2,000 participants complete the survey, the data will be de-identified and provided to the study team for analysis.

Conditions

Colorectal Cancer

Outcome Measures

Primary Outcomes (2)

• Intentions to Adhere to Colorectal Cancer Screening (CRCS) Recommendations

  After reading cancer screening (CRCS) recommendations, this outcome will assess how likely they are to follow on the the screening recommendations. Response options: Very unlikely (1), unlikely, neither unlikely nor likely, likely, very likely (5) A higher score indicates a favorable outcome, and a lower score indicates a less favorable outcome.

  15 minutes

• Intentions to Adhere Test Preference Indication

  To determine which colorectal cancer screening (CRCS) participants are most likely to choose. Response options: stool-based tests (e.g., FOBT or FIT); endoscopic/scoping approach (e.g., colonoscopy or sigmoidoscopy); whatever my doctor recommends to me; something other than a stool-based or scoping approach; I would not follow the recommendations. This outcome will report the count of responses.

  15 minutes

Secondary Outcomes (2)

• Likelihood of Sharing Information Via Social Media

  15 minutes

• Information Sharing Behavior

  15 minutes

Study Arms (5)

Control (no exposure)

PLACEBO COMPARATOR

Participants in the Control Arm will not be shown any messages.

Behavioral: Control

Median Ranked

EXPERIMENTAL

Participants in the Median Ranked Arm will be shown four Median Ranked messages.

Behavioral: Median Ranked Cancer Screening Messaging

Overall Preferred

EXPERIMENTAL

Participants in the Overall Preferred arm will be shown four Overall Preferred messages.

Behavioral: Overall Preferred Cancer Screening Messaging

Black American Preferred

EXPERIMENTAL

Participants in the Black American Preferred arm will be shown four Black American Preferred messages.

Behavioral: Black American Preferred Cancer Screening Messaging

White American Preferred

EXPERIMENTAL

Participants in the White American Preferred arm will be shown four White American Preferred messages.

Behavioral: White American Preferred Cancer Screening Messaging

Interventions

Black American Preferred Cancer Screening Messaging BEHAVIORAL

Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by Black participants but not White participants in the prior study.

Black American Preferred

White American Preferred Cancer Screening Messaging BEHAVIORAL

Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by White participants but not Black participants.

White American Preferred

Control BEHAVIORAL

There will be no message content of cancer screening and sharing intentions in this arm.

Control (no exposure)

Median Ranked Cancer Screening Messaging BEHAVIORAL

Strong message content that increases screening and sharing intentions. Messages in this intervention were median ranked in the prior study.

Median Ranked

Overall Preferred Cancer Screening Messaging BEHAVIORAL

Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by all participants in the prior study.

Overall Preferred

Eligibility Criteria

• Age: 45 Years - 75 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Identify as white/Caucasian or Black/African American.

You may not qualify if:

• Do not identify as white/Caucasian or Black/African American.
• Previously diagnosed with colorectal cancer
• Non-English speakers

Sponsors & Collaborators

• AmeriSpeak - NORC: collaborator
• University of Utah: lead
• National Cancer Institute (NCI): collaborator

Study Sites (1)

Andy King

Salt Lake City, Utah, 84112, United States

Location

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Rectal Diseases

Results Point of Contact

• Title: Andy King
• Organization: University of Utah

andy.king@utah.edu

801-646-4274

Study Officials

• Andy King, PhD

  Huntsman Cancer Institute/ University of Utah

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 19, 2024
• First Posted: December 2, 2024
• Study Start: January 9, 2025
• Primary Completion: January 21, 2025
• Study Completion: January 21, 2025
• Last Updated: March 20, 2026
• Results First Posted: March 20, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
• Time Frame: Once the primary results are published in a peer-reviewed journal article, the de-identified data will be published in an online data repository. The data will then be available for as long as the online repository is available

Locations

US (1)